文献速递心脏核医学放射性药物与辐射防护

主动脉瓣植入术后一年内18F-氟脱氧葡萄糖正电子发射断层显像/计算机断层显像的正常影像表现

Normal imaging findings after aortic valve implantation on 18F-Fluorodeoxyglucose positron emission tomography with computed tomography.
PubMed 文献 · J Nucl Cardiol · 2020-01-23

研究前瞻性纳入37例无并发症的主动脉人工心脏瓣膜植入患者,分别在术后5(±1)周、12(±2)周或52(±8)周行18F-FDG PET/CT,定性及定量评估瓣周摄取。结果显示三个时间点的瓣周摄取均以低至中等为主,SUVmax与SUVratio在各组间无显著差异。

要点

  • 无感染主动脉人工心脏瓣膜在术后5、12、52周均可表现为低至中等程度的瓣周18F-FDG摄取。
  • 三个时间点组间定性摄取分级无显著差异(P=0.91)。
  • 三个时间点组间SUVmax(P=0.08)与SUVratio(P=0.81)均无显著差异。

核心结论

  • 无感染的主动脉人工心脏瓣膜在植入后5、12和52周具有相似的低至中等程度瓣周18F-FDG摄取,SUVmax和SUVratio也相似。

研究设计与样本

  • 前瞻性纳入无并发症主动脉人工心脏瓣膜植入患者,分别在术后5(±1)周(第1组)、12(±2)周(第2组)或52(±8)周(第3组)行18F-FDG PET/CT。
  • 共纳入37例患者(第1组n=12,第2组n=12,第3组n=13),平均年龄66±8岁。
  • 对人工心脏瓣膜周围18F-FDG摄取进行定性评分(无/低/中等/高),并定量测量SUVmax和靶本比(SUVratio)。

主要发现

  • 瓣周18F-FDG摄取定性:第1组低8/12(67%)、中等4/12(33%),第2组低7/12(58%)、中等5/12(42%),第3组低8/13(62%)、中等5/13(38%),组间P=0.91。
  • SUVmax:第1组4.1±0.7,第2组4.6±0.9,第3组3.8±0.7(均值±标准差,P=0.08)。
  • SUVratio:第1组2.0[1.9至2.2],第2组2.0[1.8至2.6],第3组1.9[1.7至2.0](中位数[四分位距],P=0.81)。

关键数值与推荐

  • 定性摄取分级采用无/低/中等/高四分类。
  • 定量指标为SUVmax和靶本比(SUVratio)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To determine the normal perivalvular 18F-Fluorodeoxyglucose (18F-FDG) uptake on positron emission tomography (PET) with computed tomography (CT) within one year after aortic prosthetic heart valve (PHV) implantation. METHODS: Patients with uncomplicated aortic PHV implantation were prospectively included and underwent 18F-FDG PET/CT at either 5 (± 1) weeks (group 1), 12 (± 2) weeks (group 2) or 52 (± 8) weeks (group 3) after implantation. 18F-FDG uptake around the PHV was scored qualitatively (none/low/intermediate/high) and quantitatively by measuring the maximum Standardized Uptake Value (SUVmax) and target to background ratio (SUVratio). RESULTS: In total, 37 patients (group 1: n = 12, group 2: n = 12, group 3: n = 13) (mean age 66 ± 8 years) were prospectively included. Perivalvular 18F-FDG uptake was low (8/12 (67%)) and intermediate (4/12 (33%)) in group 1, low (7/12 (58%)) and intermediate (5/12 (42%)) in group 2, and low (8/13 (62%)) and intermediate (5/13 (38%)) in group 3 (P = 0.91). SUVmax was 4.1 ± 0.7, 4.6 ± 0.9 and 3.8 ± 0.7 (mean ± SD, P = 0.08), and SUVratio was 2.0 [1.9 to 2.2], 2.0 [1.8 to 2.6], and 1.9 [1.7 to 2.0] (median [IQR], P = 0.81) for groups 1, 2, and 3, respectively. CONCLUSION: Non-infected aortic PHV have similar low to intermediate perivalvular 18F-FDG uptake with similar SUVmax and SUVratio at 5, 12, and 52 weeks after implantation.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Wahadat AR, Tanis W, Scholtens AM, et al. Normal imaging findings after aortic valve implantation on 18F-Fluorodeoxyglucose positron emission tomography with computed tomography. J Nucl Cardiol. 2020. PMID: 31975327. doi:10.1007/s12350-019-02025-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。